NewsBenzingaHerbalife prevede vendite del quarto trimestre tra 1,289 miliardi di dollari e 1,341 miliardi di dollari, contro i 1,304 miliardi stimati Herbalife prevede vendite del quarto trimestre tra 1,289 miliardi di dollari e 1,341 miliardi di dollari, contro i 1,304 miliardi stimati Benzinga 2026.11.02 21:22 (GMT+0) Open on Benzinga Other news UBS Maintains Neutral on Carter's, Lowers Price Target to $33 Apple CFO Says Apple Operating Expenses Climbed 21% Due To R&D Investments UBS Maintains Buy on Willis Towers Watson, Lowers Price Target to $395 Apple CFO Says Gross Margins Would Have Been Down Without Tariff Refunds Due To High Memory Costs UBS Maintains Neutral on Vale, Lowers Price Target to $13.5 Equitable Says Merger With Corebridge Financial Remains On Track To Close By Year-End 2026
